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ABSTRACT
Introduction: The aim of this study was to determine the pattern of histopathological types of breast cancer in 
women aged 70 years or more with operable early breast cancer, and its implication on the potential prognosis.
Methodology & Material: A retrospective cohort study included 170 patients hospitalised for breast cancer 
treatment in departments of surgery of two teaching hospitals (Basildon University Hospital, Basildon, United 
Kingdom, and Greater Poland Oncology Centre, Poznan, Poland).
Material and methods: All 170 patients underwent surgical management for breast cancer. Invasive ductal 
carcinoma (IDC) was the most common histopathological type in the study group (74%). The mucinous 
carcinoma was seen in 1.7% of cases, invasive lobular carcinoma in only 1% of patients, while the ductal 
carcinoma in situ was present in 6.5% of subjects. Lympho-vascular invasion was detected in 23% of cases.
Conclusion: Less aggressive histological pattern was predominantly detected in the elderly patients with 
breast cancers.
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Introduction 
It is well known that the incidence of breast cancer 
increases with age, and that this disease is a leading cause 
of death among women. Increased risk for breast cancer is 
associated with late first pregnancy, lack of breast feeding 
history, late menopause, use of hormonal replacement 
therapy (HRT), smoking and obesity [1]. The median age 
of breast cancer diagnosis is 60 years old, and over 40% 
of new cases are diagnosed in women aged 65 years or 
older [2]. It was suggested that advanced age may affect 
biological characteristics of breast cancer [3].
The available data indicate that breast cancer has 
a relatively good prognosis among the elderly patients, 
and unfavourable prognosis in young patients [4–6]. 
The literature reveals that invasive ductal carcinoma 
(Figure 1) accounts for 80% of breast cancer, and that 
lobular invasive carcinoma (Figure 2) and mucinous 
carcinoma are relatively more frequent in older patients 
[4] .It was reported that intra-cystic papillary carcinoma 
is more frequent in older patients [7].
The aim of this study was to review the histopatho-
logical tumour types in relation to age of patients with 
Figure 1. Grade 2 Invasive Ductal carcinoma of Breast.: 
Sheaths and nests of pleomorphic cells with cellular atypia 
and prominent mitotic figures
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Table 1. Invasive and non-invasive breast neoplasm in patients above 70 years of age.
Results
sAge Group 70-75 Yrs 76-80 Yrs >80 Yrs Total
Total 65[38.2%] 65[38.2%] 40[23.5%] 170[110%]
Invasive Ductal Carcinoma (IDC) 44[25.8%] 54[31.7%] 29[17%] 127[74.7%]
 Grade I IDC 11[6.47%] 11[6.47%] 5[2.94%] 27[15.8%]
 Grade II IDC 21[12.3%] 24[14.1%] 14[8.23%] 59[34.7%]
 Grade IIII IDC 12[7.05%] 19[11.1%] 10[5.88%] 41[24.1%]
Invasive Lobular Carcinoma (ILC) 8[4.70%] 4[2.35%] 5[2.94%] 17[10%]
Mucinous 0[0%] 2[[1.17%] 1[0.588%] 3[1.76%]
Mixed + Other 7[4.11%] 3[1.76%] 1[0.588%] 11[6.47%]
Ductal Carcinoma in situ 6[3.52%] 2[1.17%] 4[2.35%] 12[7.05%]
Figure 2. Breast  invasive lobular carcinoma: single 
neoplastic cell infiltration of the stroma
Results
The age structure of the study population was: 
70–75 years old - 38%, 76-80 years old - 38%, and 
above 80 years old - 24%, as shown in Table 1. Invasive 
ductal carcinoma (IDC) was the most common histo-
pathological type in the study group, and accounted 
for 74% cases of breast cancer (Figures 3 and 4). In 
this subgroup, it was noticed that grade 2 IDC was the 
most frequent (35%), followed by grade 3 IDC (24%) 
and grade 1 IDC (15%). In the examined cohort, invasive 
lobular carcinoma was present in 10% of cases, and 
mucinous carcinoma was seen in only 1.7% of cases, 
whereas ductal carcinoma in situ occurred in 6.5% of 
patients. The lympho-vascular invasion was present in 
23% of all cases and absent in 69%. It was not applica-
ble in 7% of cases which were invasive ductal carcinoma 
in situ, (Figure 5).
Discussion
Breast cancer is the most common human neoplasm 
with more than 1,000,000 cases occurring worldwide 
annually [8], the most common malignant disease in 
women worldwide (25%), that accounts for 27% of can-
cers in developed countries, and is the leading cause 
of mortality in women [9–11]. The number of elderly 
breast cancer patients is rising as a result of increase 
in the aged population. Advanced age is a known risk 
factor for the breast cancer. An increased risk for breast 
cancer is observed if the advanced age is associated 
with late first pregnancy, lack of breast feeding history, 
late menopause, use of HRT, smoking and obesity 
[1, 12]. The average age at the time of breast cancer 
diagnosis is 61 years, and the majority of breast cancer 
related deaths occur at age of 65 years or older. Only 
about 30–35% of patients with breast cancer are older 
than 70 years of age, while approximately 45–50% are 
breast cancer, and to determine potential indicators 
of more aggressive characteristics in different age 
groups. 
Patients and methods
The study comprised of 170 women aged 70 years 
or more with invasive and non-invasive breast cancer 
who were treated surgically at the Breast Unit, Basildon 
University Hospital, Basildon, United Kingdom, and 
Greater Poland Oncology Centre, Poznan, Poland, 
between 2011 and 2016. Included patients had breast 
conservation procedure or mastectomy, and axillary 
surgery when indicated. The patients were divided into 
three age subgroups: 70–75 years old, 76–80 years old 
and above 80 years old. Patients with bilateral disease 
were included only once. We analysed the histopatho-
logical diagnosis, grade of the tumour in the invasive 
ductal carcinoma, and presence of lympho-vascular 
invasion, which was reported as present or absent. 
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Figure 3. Histopathology of operated breast cancer in 170 patients aged above 70 years
Figure 4. Histopathological Types of Breast Cancer in Operated 170 females all aged above 70 years- distribution in 
age subgroups
65 years or older [1,13]. There are reports that, with 
advanced age breast cancer may change its biological 
characteristics. The studies suggest that advanced 
age might be associated with more favourable tumor 
biology [14], and that breast cancer has a relatively 
good prognosis among the elderly patients, while the 
prognosis is less favourable in younger patients [4–6]. 
Breast cancer is well known to be a heterogeneous 
disease with multiple pathological varities associated 
with distinctive histopathological features. Breast cancer 
is divided into carcinoma in situ and invasive adeno-
carcinoma. In carcinoma in situ, the neoplastic cells 
are restrained inside the mammary ductal-lobular unit, 
whereas in invasive carcinoma neoplastic cells spread 
beyond that unit [15].
There is a long-standing believe regarding the 
histological origin of breast adenocarcinoma. Cancers 
originating from the ducts are known as ductal carci-
nomas, while those originating from the lobules are 
known as lobular. However, this has been challenged 
by Wellings and Jensen (1973) and Wellings et al. 
(1975). The new concept demonstrated that the breast 
carcinoma in situ and a wide variety of invasive breast 
adenocarcinoma arise from the terminal duct-lobular 
type regardless of the category of the histopathology. 
The use of ductal and lobular carcinoma division, by 
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Figure 5. LVI: Lympho-vascular invasion in resected breast cancer of 170 patients aged above 70 years
no means is related to the origin of cancer within the 
mammary tissue. The histopathological classification of 
the breast adenocarcinoma should be determined by 
their distinct architectural features, cellular structures 
and immunohistochemistry [16–17].
The breast cancer is more aggressive in younger 
patients [18–19]. Our paper shows that 46% of all IDC 
cases were grade 2, which accounted for 35% of all 
cases in the study cohort. Grade 1 and 2 IDC together 
accounted for 50% of all cases, and 68% in the invasive 
ductal carcinoma group. Therefore, our results are in 
line with the concept of that the disease is less aggres-
sive in the older patients. The studies have shown that 
the comorbid conditions are associated with decreased 
overall survival in the breast cancer patients rather than 
presence of the cancer itself [20].
The literature mentions that median age of Cauca-
sian patients with invasive lobular carcinoma is slightly 
higher than that of patients with invasive ductal car-
cinoma [21]. Mucinous carcinoma also occurs more 
frequently in older patients [4, 22]. In our study only 1% 
of patients had invasive lobular carcinoma and 1.8 % 
had mucinous carcinoma. Invasive lobular carcinoma 
and mucinous carcinoma usually present as small, 
slow-growing tumours with low grade histopathology, 
positive hormonal receptors, negative Her2 receptors 
and normal p53 [21–22]. Both of these types are known 
to have a better prognosis than invasive ductal carci-
noma [18]. Tubular carcinoma is yet another breast 
cancer that is more likely to occur in older patients [22].
LVI is a significant predictor of poor prognosis in 
invasive breast cancer. In our study population, it was 
present only in less than one quarter of all cases. LVI is 
taken into account while planning a systemic adjuvant 
therapy, such as chemotherapy [23].
Conclusion
The available evidence suggests that there are po-
tential age-related changes in the histology of breast 
cancer, as well as less aggressive forms of breast 
cancer in the elderly.
The results of the present study are in line with 
the current reports regarding cancer diagnosis in the 
older patients.
The breast cancer in not uncommon in the elderly 
and selection of treatment should be based on the 
histopathological type, overall medical condition, and 
not on the patient’s age. The elderly women with a life 
expectancy of more than 10 years should be routinely 
considered in the mammography-based screening pro-
grams.
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